Myeloma Nurse Learning Programme Module 1 – Overview and epidemiology of myeloma Key points

Key points

  • Myeloma is a malignancy of plasma cells
  • Myeloma is characterised by the presence of abnormal plasma cells in the bone marrow and the production of a monoclonal antibody
  • Myeloma is frequently associated with bone pain, anaemia and renal damage
  • Myeloma represents about 2% of all cancers
  • There are approximately 6200 new cases of myeloma each year in the UK
  • Myeloma is most prevalent in adults over 65 years old, but it affects younger patients too.
  • The causes of myeloma are unknown but both genetic and environmental factors may be associated
  • Myeloma is treatable, but not yet curable: 10-year survival rates are approximately 33%
  • The outlook for myeloma patients is improving with the advent of novel drugs and advances in supportive care
  • Patients need information, support and continuity of care within the multidisciplinary team
Previous Section
Back to Module
Next Assessment